# US 2014/0273026 A1 · Methods for Detecting Ehrlichia Infection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0273026 A1
- Document ID: US20140273026A1
- Status: Published application
- Kind: A1
- Application number: 14/174,815
- Filed: 2014-02-06
- Published: 2014-09-18
- Earliest claimed: 2009-11-13
- Assignees: Board of Regents, The University of Texas System
- Inventors: David H. Walker; Sunil Thomas
- Web page: https://patentgrep.com/patent/US20140273026A1

## CPC

- G01N 33/56911: {Bacteria}
- A61K 39/0233: {Rickettsiales, e.g. Anaplasma}
- A61P 31/04: Antibacterial agents
- A61P 37/04: Immunostimulants
- C07K 14/29: from Richettsiales (O)
- C07K 16/1246: Rickettsiales (O)
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61K 2039/6081: {Albumin; Keyhole limpet haemocyanin [KLH]}
- C07K 2317/34: Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present invention provides an isolated and purified heat shock protein 60 (Hsp60) peptide having the amino acid sequence of SEQ ID NO:2. The instant invention is also directed to a vaccine against Ehrlichia comprising a peptide homologous to the amino acid sequence of SEQ ID NO:2. The instant invention is also directed to an antibody directed against a peptide homologous to the amino acid sequence of SEQ ID NO:2. The instant invention is also directed to a method of determining whether a subject is infected with Ehrlichia, comprising the steps of: contacting a sample from a subject with the antibody described herein; and detecting a resulting antibody reaction, wherein a positive reaction indicates the subject is infected with Ehrlichia.

## Claims

### Claim at position 1

-17. (canceled)

### Claim 18

A method for detecting Ehrlichia in a subject comprising the steps of:
contacting a sample from the subject with a 21 amino acid peptide having the sequence of SEQ ID NO:2 or an antibody that specifically binds the peptide having the amino acid sequence of SEQ ID NO:2; and
detecting the binding of the peptide or the binding of an antibody that binds the peptide to components in the sample, wherein detection of binding indicates the subject is infected with Ehrlichia.

### Claim 19 (depends on 18)

The method of claim 18, wherein said subject is a dog.

### Claim 20 (depends on 18)

The method of claim 18, wherein said sample is serum.

### Claim 21 (depends on 18)

The method of claim 18, wherein said Ehrlichia is Ehrlichia chaffeensis, Ehrlichia muris, Ehrlichia ewingii, Ehrlichia ruminantium, or Ehrlichia canis.

### Claim 22

A serodiagnostic kit for determining whether a subject is infected with Ehrlichia, said kit comprising:
a 21 amino acid peptide having the sequence of SEQ ID NO:2 or an antibody that specifically binds the peptide having the amino acid sequence of SEQ ID NO:2an.

### Claim 23 (depends on 22)

The kit of claim 22, wherein the peptide or antibody specific for the peptide are couple to a reporter molecule.

### Claim 24 (depends on 23)

The kit of claim 23, wherein the reporter molecule is selected from the group consisting of luciferase, horseradish peroxidase, P-galactosidase, and fluorescent labels
